Cerebrospinal Fluid Neuropeptide Y Levels in Major Depression and Reported Childhood Trauma

被引:18
|
作者
Soleimani, Laili [1 ]
Oquendo, Maria A. [2 ,3 ]
Sullivan, Gregory M. [2 ,3 ]
Mathe, Aleksander A. [5 ]
Mann, J. John [2 ,3 ,4 ]
机构
[1] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA
[2] New York State Psychiat Inst & Hosp, Div Mol Imaging & Neuropathol, New York, NY 10032 USA
[3] Columbia Univ, Dept 3Psychiat, New York, NY USA
[4] Columbia Univ, Dept Radiol, New York, NY USA
[5] Karolinska Inst, Div Psychiat, Stockholm, Sweden
来源
基金
英国医学研究理事会;
关键词
childhood trauma; CSF; major depression; neuropeptide Y; CORTICOTROPIN-RELEASING HORMONE; RAT-BRAIN; CSF; SCHIZOPHRENIA; DISORDERS; SEROTONIN; ANXIETY; EXPRESSION; STRESS; CORTEX;
D O I
10.1093/ijnp/pyu023
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Neuropeptide Y (NPY) may enhance resilience to chronic stress. Low brain NPY reported in major depression may normalize in response to antidepressants. Methods: In this study, we examined the relationship of reported childhood trauma to cerebrospinal fluid (CSF) NPY-like immunoreactivity (NPY-LI) in 61 medication-free major depressive disorder (MDD) patients and 20 matched healthy volunteers. Results: Higher CSF NPY-LI was found in MDD compared to the healthy volunteer group (p = 0.01). A positive correlation of CSF NPY-LI with more adverse childhood trauma (p = 0.001) may be indicative of an intact but insufficient NPY-related stress response. Conclusions: We hypothesize that differences in published results may be explained by the existence of two groups of MDD in terms of CSF NPY levels: MDD with low CSF NPY prior to stress or in response to stress, and those with robust NPY responses to stress. Future studies should confirm the two groups and seek the molecular mechanism for their differences.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Cerebrospinal Fluid Neuropeptide Y Levels in Major Depression and Reported Childhood Abuse
    Soleimani, Laili
    Oquendo, Maria A.
    Sullivan, Gregory M.
    Mathe, Aleksander A.
    Mann, J. John
    BIOLOGICAL PSYCHIATRY, 2013, 73 (09) : 179S - 179S
  • [2] CEREBROSPINAL-FLUID NEUROPEPTIDE-Y IN DEPRESSION AND SCHIZOPHRENIA
    BERRETTINI, WH
    DORAN, AR
    KELSOE, J
    ROY, A
    PICKAR, D
    NEUROPSYCHOPHARMACOLOGY, 1987, 1 (01) : 81 - 83
  • [3] NEUROPEPTIDE-Y AND PEPTIDE-YY AS POSSIBLE CEREBROSPINAL-FLUID MARKERS FOR MAJOR DEPRESSION AND SCHIZOPHRENIA, RESPECTIVELY
    WIDERLOV, E
    LINDSTROM, LH
    WAHLESTEDT, C
    EKMAN, R
    JOURNAL OF PSYCHIATRIC RESEARCH, 1988, 22 (01) : 69 - 79
  • [4] Cytokine levels in major depression are related to childhood trauma but not to recent stressors
    Grosse, Laura
    Ambree, Oliver
    Joergens, Silke
    Jawahar, M. Catharine
    Singhal, Gaurav
    Stacey, David
    Arolt, Volker
    Baune, Bernhard T.
    PSYCHONEUROENDOCRINOLOGY, 2016, 73 : 24 - 31
  • [5] Neuropeptide Y-like immunoreactivity in lumbar cerebrospinal fluid of patients after severe head trauma
    Stachura, Z
    Obuchowicz, E
    Herman, ZS
    NEUROPEPTIDES, 1997, 31 (01) : 12 - 14
  • [6] NEUROPEPTIDE-Y LEVELS IN CENTRAL AND PERIPHERAL CEREBROSPINAL-FLUID IN PATIENTS WITH INTRACRANIAL DISORDERS
    VONHOLST, H
    RUDEHILL, A
    LUNDBERG, JM
    ACTA NEUROCHIRURGICA, 1991, 112 (3-4) : 132 - 135
  • [7] Variation in cerebrospinal fluid levels of neuropeptide Y, cholecystokinin and substance P in patients with neurological disorders
    Qureshi, GA
    Baig, SM
    Collin, C
    Parvez, SH
    NEUROENDOCRINOLOGY LETTERS, 2000, 21 (05) : 409 - 416
  • [8] Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression:: preliminary evidence for association with preproNPY gene polymorphism
    Heilig, M
    Zachrisson, O
    Thorsell, A
    Ehnvall, A
    Mottagui-Tabar, S
    Sjögren, M
    Åsberg, M
    Ekman, R
    Wahlestedt, C
    Ågren, H
    JOURNAL OF PSYCHIATRIC RESEARCH, 2004, 38 (02) : 113 - 121
  • [9] 'Cerebrospinal fluid neuropeptide Y in Prader-Willi syndrome'
    Åkefeldt, A
    Ekman, R
    Månsson, JE
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2001, 43 (04): : 286 - 287
  • [10] NEUROPEPTIDE-Y IMMUNOREACTIVITY IN HUMAN CEREBROSPINAL-FLUID
    BERRETTINI, WH
    NURNBERGER, JI
    DIMAGGIO, DA
    PEPTIDES, 1986, 7 (03) : 455 - 458